Literature DB >> 748983

Prostaglandin-mediated hyperemia and renin-mediated hypertension during acute ureteral obstruction.

P Cadnapaphornchai, G Aisenbrey, K M McDonald, T J Burke, R W Schrier.   

Abstract

Acute elevation of ureteral pressure to 100 mm Hg in anesthetized dogs (n=7) resulted in an increase (P less than 0.005) in systemic blood pressure form 151 +/- 7 to 163 +/- 7 mm Hg, a transient (approximately 15 min) increase (P less than 0.05) in renal blood flow from 413 +/- 27 to 465 +/- 27 ml/min and a rise (P less than 0.05) in plasma renin activity from 6.0 +/- 1.6 to 10.3 +/- 2.1 ng/ml/hr. Pretreatment with a competitive inhibitor of angiotensin II, i.e. sar1gly8AII, abolished the hypertensive response to acute ureteral obstruction, and pretreatment with 2 mg/kg of either indomethacin (n=6) or meclofenamate (n=3), 15 min before obstruction, prevented the hyperemic response. These results suggest that acute ureteral obstruction leads to hypertension via activation of the renin-angiotensin system and hyperemia via a prostaglandin-initiated mechanism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748983     DOI: 10.1016/0090-6980(78)90113-2

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

Review 1.  Hypertension in infancy: diagnosis, management and outcome.

Authors:  Janis M Dionne; Carolyn L Abitbol; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-01-22       Impact factor: 3.714

Review 2.  The long-term renal effects of short periods of unilateral ureteral obstruction.

Authors:  Fayez T Hammad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

3.  Ureteral blockade sensitizes to the generalized Shwartzman reaction.

Authors:  J G Latour; C Léger-Gauthier
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

4.  Adenosine induced fall in glomerular capillary pressure. Effect of ureteral obstruction and aortic constriction in the Munich-Wistar rat kidney.

Authors:  J A Haas; H Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.